Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anna-Karin Hamberg"'
Autor:
Sofia Attelind, Pär Hallberg, Mia Wadelius, Anna-Karin Hamberg, Agneta Siegbahn, Christopher B. Granger, Renato D. Lopes, John H. Alexander, Lars Wallentin, Niclas Eriksson
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Apixaban is a direct oral anticoagulant, a factor Xa inhibitor, used for the prevention of ischemic stroke in patients with atrial fibrillation. Despite using recommended dosing a few patients might still experience bleeding or lack of efficacy that
Externí odkaz:
https://doaj.org/article/d681fd40c0f0401798dc35d38932f5df
Autor:
Kunihiko Itoh, Tina T. Biss, Mia Wadelius, Fanny Bajolle, Kaitlyn Shaw, Anna-Karin Hamberg, Masanobu Takeuchi, Takuya Wakamiya, Masakatsu Yanagimachi, Masato Taguchi, Marie-Anne Loriot, Keita Hirai, Leonardo R. Brandão, Bruce Carleton, Richard H. Ho, Susan I. Vear, Shinya Ito, Farhad Kamali, Tohru Kobayashi, Keiichi Hirono
Publikováno v:
The pharmacogenomics journal. 20(2)
Studies on the effect of cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1), and cytochrome P450 4F2 (CYP4F2) polymorphisms on warfarin maintenance dose in children are conflicting. We conducted a systematic review a
Autor:
Ron Keizer, Anna-Karin Hamberg
Publikováno v:
Therapeutic drug monitoring. 39(3)
Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve? : A Commentary
Autor:
Flora Musuamba Tshinanu, Frederike Lentz, Wei Zhao, Anna Karin Hamberg, Norbert Benda, Joseph F. Standing, Cecile Ollivier, Andrew Thomson, Sofia Friberg Hietala, Efthymios Manolis, Gérard Pons, Susan Cole, Paolo Tomasi, Ine Skottheim Rusten, María J. Garrido, Valeria Gigante, Ralf Herold, Anna Nordmark, Johannes Taminiau
Publikováno v:
Fundamentals of Pediatric Drug Dosing ISBN: 9783319437521
For a paediatric development to be rationally informed by all available knowledge, it is necessary to systematically collect and learn from available data, expert knowledge and prior developments. Aspects such as drug formulation, bioanalytical metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5211cde2b733f8349acdf1c43ee24f18
https://doi.org/10.1007/978-3-319-43754-5_7
https://doi.org/10.1007/978-3-319-43754-5_7
Publikováno v:
British Journal of Haematology. 159:106-109
Publikováno v:
BMC Medical Informatics and Decision Making
Background Warfarin is the most widely prescribed anticoagulant for the prevention and treatment of thromboembolic events. Although highly effective, the use of warfarin is limited by a narrow therapeutic range combined with a more than ten-fold diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f09b21d7b9b946ea8de9b2550418c71d
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-197598
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-197598
Autor:
Mia Wadelius, Anna-Karin Hamberg
Publikováno v:
Pharmacogenomics. 15(3)
Clinical factors, demographic variables and variations in two genes, CYP2C9 and VKORC1, have been shown to contribute to the variability in warfarin dose requirements among adult patients. Less is known about their relative importance for dose variab
Autor:
Tina T. Biss, Mia Wadelius, E. Niclas Jonsson, Lena E. Friberg, Anna-Karin Hamberg, Farhad Kamali
Publikováno v:
British Journal of Clinical Pharmacology
Aims Although genetic, clinical and demographic factors have been shown to explain approximately half of the inter-individual variability in warfarin dose requirement in adults, less is known about causes of dose variability in children. This study a
Autor:
Anna-Karin Hamberg, Marja-Liisa Dahl, Jonsson En, Anders Rane, Roberto Padrini, Panagiotis Deloukas, Jonatan D. Lindh, Mia Wadelius
The objective of the study was to update a previous NONMEM model to describe the relationship between warfarin dose and international normalized ratio (INR) response, to decrease the dependence of the model on pharmacokinetic (PK) data, and to improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92f0f9ad912d72cf841f97eecbadde3
http://hdl.handle.net/11577/2426524
http://hdl.handle.net/11577/2426524
Autor:
Magnus Gisslén, Jane Ahlqvist-Rastad, Jan Albert, Anders Blaxhult, Anna-Karin Hamberg, Stefan Lindbäck, Eric Sandström, Ingrid Uhnoo, Anders Sönnerborg, null FOR THE SWEDISH CONSENSUS GROUP
Publikováno v:
Scandinavian journal of infectious diseases. 38(2)
On 2 earlier occasions, in 2002 and 2003, the Swedish Medical Products Agency (MPA) and the Swedish Reference Group for Antiviral Therapy (RAV) have jointly publicized recommendations for the treatment of HIV infection. A working group from the same